Nu Skin Enterprises Inc. Cl A (NUS) Tops Q2 EPS by 6c, Posts Q3 and Updates FY11 Guidance
Nu Skin Enterprises Inc. Cl A (NYSE: NUS) reported Q2 EPS of $0.65, $0.06 better than the analyst estimate of $0.59. Revenue for the quarter came in at $424.4 million versus the consensus estimate of $406.51 million.
Nu Skin Enterprises Inc. Cl A sees Q3 2011 EPS of $0.58-$0.61, versus the consensus of $0.59. Nu Skin Enterprises Inc. Cl A sees Q3 2011 revenue of $405-$415 million, versus the consensus of $406.65 million.
Nu Skin Enterprises Inc. Cl A sees FY2011 EPS of $2.38-$2.46, versus the consensus of $2.39. Nu Skin Enterprises Inc. Cl A sees FY2011 revenue of $1.655-$1.675 billion, versus the consensus of $1.65 billion.
Nu Skin Enterprises Inc. Cl A sees Q3 2011 EPS of $0.58-$0.61, versus the consensus of $0.59. Nu Skin Enterprises Inc. Cl A sees Q3 2011 revenue of $405-$415 million, versus the consensus of $406.65 million.
Nu Skin Enterprises Inc. Cl A sees FY2011 EPS of $2.38-$2.46, versus the consensus of $2.39. Nu Skin Enterprises Inc. Cl A sees FY2011 revenue of $1.655-$1.675 billion, versus the consensus of $1.65 billion.
